[Case Study] Keisuke Kagami and Mitsuru Sugawara “Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.” (AMR Alliance Japan, February 22, 2022)
date : 2/22/2022
Tags: AMR
![[Case Study] Keisuke Kagami and Mitsuru Sugawara “Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.” (AMR Alliance Japan, February 22, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-case05_ENG-top.jpg)
As part of the Alliance’s project to promote antimicrobial steward among medical professionals, AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) has begun publishing case studies from various experts related to antimicrobial resistance.
Dr. Keisuke Kagami (Department of Pharmacy, Hokkaido University Hospital) and Dr. Mitsuru Sugawara (Department of Pharmacy, Hokkaido University Hospital / Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hokkaido University) reports a case titled “Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.”
In this study, the usefulness of TDM (Therapeutic Drug Monitoring) for antimicrobial stewardship is reported.
Case study 05
Dr. Keisuke Kagami (Department of Pharmacy, Hokkaido University Hospital)
Dr. Mitsuru Sugawara (Department of Pharmacy, Hokkaido University Hospital / Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hokkaido University)
“Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.”
For further information, please see the case study below.
Case study 01
Dr. Keiji Okinaka (Director of Infection Control and Prevention Section, National Cancer Center Hospital East / Department of General Internal Medicine, National Cancer Center Hospital East /Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital)
“A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment”
Case study 04
Dr. Akari Shigemi (Division of Pharmacy / Department of Infection Control and Prevention, Kagoshima University Hospital)
“The importance of proper antimicrobial use for MRSA infections – Beware of rifampicin monotherapy induced resistance”
![[AMR Case Study 04] Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury](/assets/img/katsudo/icon_pdf_l.png){kind=icon}
Top Research & Recommendations Posts
- [Public Comment Submission] “Basic Plan for the Promotion of Cancer Control (Draft)” (February 18, 2023)
- [Urgent Recommendations] Challenges and Prospects for the Implementation and Execution of the Basic Law and Basic Policy for Child and Maternal Health and Development (February 17, 2023)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022）
- [Publication Report] The Children’s Health Project Publishes Family Mental Health Booklet “Nurturing Child and Guardian Mental Health through Our Communication with Children” in Five Languages (February 6, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
Featured Posts
-
2022-12-26
[Event Report] The Health and Global Policy Institute Chronic Disease Control Project Holds Advisory Board Meeting for “Engaging and Cooperating with Patients, Citizens, and Communities for Obesity Prevention” (September 22, 2022)
![[Event Report] The Health and Global Policy Institute Chronic Disease Control Project Holds Advisory Board Meeting for “Engaging and Cooperating with Patients, Citizens, and Communities for Obesity Prevention” (September 22, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/ncd-ob-20220922-top.jpg)
-
2023-03-06
[In the Media] What Healthy Climate Prescription Teaches Us: Health Care’s Approach to the Climate Crisis (Min-Iren Iryo, No. 606; February 24, 2023)
![[In the Media] What Healthy Climate Prescription Teaches Us: Health Care’s Approach to the Climate Crisis (Min-Iren Iryo, No. 606; February 24, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/lecture-media-210-top.png)
-
2023-03-09
[Event Report] HGPI Special Seminar – Universal Health Coverage in an Era of Antimicrobial Resistance (August 18, 2022)
![[Event Report] HGPI Special Seminar – Universal Health Coverage in an Era of Antimicrobial Resistance (August 18, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/uhc-shs-20220818-1-top_JPNENG.jpg)
-
2023-03-15
[Event Report] The Cardiovascular Disease Control Promotion Project, Phase 2. “Current Issues and Prospects for Advancing Cardiovascular Disease Control Promotion Plans in Each Prefecture” (March 15, 2023)
![[Event Report] The Cardiovascular Disease Control Promotion Project, Phase 2. “Current Issues and Prospects for Advancing Cardiovascular Disease Control Promotion Plans in Each Prefecture” (March 15, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/ncd-cd-20230315-top-scaled-1.jpg)
